Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

[Editorial. Spasticity in multiple sclerosis].

Vermersch P.

Rev Neurol (Paris). 2012 Apr;168 Suppl 3:S35. doi: 10.1016/S0035-3787(12)70044-9. French. No abstract available.

PMID:
22721362
2.

[Spasticity in multiple sclerosis].

Pappalardo A, Patti F, Reggio A, Guglielmino A, Mangiameli S.

Clin Ter. 2004 Apr;155(4):135-8. Review. Italian.

PMID:
15354762
3.

Spasticity: a common symptom of multiple sclerosis.

Currie R.

Nurs Stand. 2001 May 2-8;15(33):47-52; quiz 54-5. Review.

PMID:
12216268
4.

Overview of spasticity management in multiple sclerosis. Evidence-based management strategies for spasticity treatment in multiple sclerosis.

Haselkorn JK, Balsdon Richer C, Fry Welch D, Herndon RM, Johnson B, Little JW, Miller JR, Rosenberg JH, Seidle ME; Multiple Sclerosis Council for Clinical Practice Guidelines.

J Spinal Cord Med. 2005;28(2):167-99. No abstract available.

PMID:
15889701
5.

[Spasticity and everyday life in multiple sclerosis].

Donzé C, De Sèze J.

Rev Neurol (Paris). 2012 Apr;168 Suppl 3:S51-6. doi: 10.1016/S0035-3787(12)70047-4. Review. French.

PMID:
22721365
6.

New insights into multiple sclerosis and advances in multiple sclerosis spasticity management.

Gold R.

Expert Rev Neurother. 2013 Dec;13(12 Suppl):1-2. doi: 10.1586/14737175.2013.865865. No abstract available.

PMID:
24289835
7.

Overview of MS spasticity.

Pozzilli C.

Eur Neurol. 2014;71 Suppl 1:1-3. doi: 10.1159/000357739. Epub 2014 Jan 22. No abstract available.

PMID:
24457845
8.

Muscle rupture caused by exacerbated spasticity in a patient with multiple sclerosis.

Patejdl R, Winkelmann A, Benecke R, Zettl UK.

J Neurol. 2008 Dec;255 Suppl 6:115-8. doi: 10.1007/s00415-008-6021-y.

PMID:
19300971
9.

Advances in the management of multiple sclerosis-related spasticity.

Hartung HP.

Expert Rev Neurother. 2012 Apr;12(4 Suppl):1. doi: 10.1586/ern.12.10. No abstract available.

PMID:
22509984
10.

Multiple sclerosis.

Hawker K, Frohman E.

Prim Care. 2004 Mar;31(1):201-26. Review. No abstract available.

PMID:
15110166
11.

Tizanidine vs. baclofen in the treatment of spasticity in patients with multiple sclerosis.

Rice GP.

Can J Neurol Sci. 1989 Nov;16(4):451. No abstract available.

PMID:
2804809
12.

Spasticity, ataxia and fatigue in multiple sclerosis.

Kesselring J, Thompson AJ.

Baillieres Clin Neurol. 1997 Oct;6(3):429-45. Review.

PMID:
10101582
13.

Total knee replacement in patients with multiple sclerosis.

Shannon FJ, Cogley D, Glynn M.

Knee. 2004 Dec;11(6):485-7.

PMID:
15581769
14.

The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis.

Leary SM, Thompson AJ.

J Neurol Neurosurg Psychiatry. 2004 Mar;75(3):508-9. No abstract available.

15.

[Long-term treatment of spasticity with tisanidine (sirdulad) in 2 cases of multiple sclerosis].

Cendrowski W.

Wiad Lek. 1987 Dec 15;40(24):1711-4. Polish. No abstract available.

PMID:
3451608
16.

Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis.

Centonze D, Koch G, Versace V, Mori F, Rossi S, Brusa L, Grossi K, Torelli F, Prosperetti C, Cervellino A, Marfia GA, Stanzione P, Marciani MG, Boffa L, Bernardi G.

Neurology. 2007 Mar 27;68(13):1045-50.

PMID:
17389310
17.

Muscle relaxants in multiple sclerosis.

Basmajian JV.

Int Disabil Stud. 1987;9(2):90-1.

PMID:
3680109
18.

[Symptomatic therapies for multiple sclerosis].

Honda H.

Nihon Rinsho. 2003 Aug;61(8):1355-60. Review. Japanese.

PMID:
12962023
19.

Clinical assessment of pelvic floor dysfunction in multiple sclerosis: urodynamic and neurological correlates.

De Ridder D, Vermeulen C, De Smet E, Van Poppel H, Ketelaer P, Baert L.

Neurourol Urodyn. 1998;17(5):537-42.

PMID:
9776017
20.

[Conclusion].

Bensmail D.

Rev Neurol (Paris). 2012 Apr;168 Suppl 3:S69. doi: 10.1016/S0035-3787(12)70050-4. French. No abstract available.

PMID:
22721368

Supplemental Content

Support Center